Zolpidem for insomnia
- 19 March 2012
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Pharmacotherapy
- Vol. 13 (6), 879-893
- https://doi.org/10.1517/14656566.2012.667074
Abstract
Introduction : The imidazopyridine derivative zolpidem, which acts as a benzodiazepine (BZ) receptor agonist, is the most widely prescribed hypnotic drug in the US. Areas covered : This review addresses the neuroreceptor properties of zolpidem; clinical pharmacokinetics, pharmacodynamics and drug interactions; efficacy as a hypnotic; adverse effects; tolerance, dependence and withdrawal; relation to motor vehicle accidents and complex sleep behaviors; and new dosage forms. Expert opinion : Approved doses of zolpidem (10 mg for adults, 5 mg for the elderly) are consistently effective in reducing sleep latency and consequently increasing sleep duration in patients with insomnia. However, favorable effects on sleep maintenance are observed less consistently. Residual daytime effects are unlikely with recommended doses, and provided that at least 8 h elapse prior to arising. Hypnotic efficacy is maintained with repeated nightly use, and the risk of rebound insomnia is low. Dependence and abuse of zolpidem are no more likely to occur than with typical benzodiazepines. Newly available novel dosage forms of zolpidem have increased therapeutic options for patients with insomnia variants such as sleep maintenance insomnia and middle-of-the-night awakening.Keywords
This publication has 97 references indexed in Scilit:
- Acute effects of zolpidem extended-release on cognitive performance and sleep in healthy males after repeated nightly use.Experimental and Clinical Psychopharmacology, 2012
- Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypesNature Reviews Drug Discovery, 2011
- Spontaneous adverse event reports associated with zolpidem in Australia 2001-2008Journal of Sleep Research, 2011
- GABAA receptors: Subtypes provide diversity of function and pharmacologyNeuropharmacology, 2009
- Daytime pharmacodynamic and pharmacokinetic evaluation of low‐dose sublingual transmucosal zolpidem hemitartrateHuman Psychopharmacology: Clinical and Experimental, 2007
- The Efficacy and Safety of Drug Treatments for Chronic Insomnia in Adults: A Meta-analysis of RCTsJournal of General Internal Medicine, 2007
- Concentrations of Scheduled Prescription Drugs in Blood of Impaired Drivers: Considerations for Interpreting the ResultsTherapeutic Drug Monitoring, 2007
- Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network surveyBritish Journal of Clinical Pharmacology, 2007
- Effect of voriconazole on the pharmacokinetics and pharmacodynamics of zolpidem in healthy subjectsBritish Journal of Clinical Pharmacology, 2007
- Pharmacokinetic properties of zolpidem in elderly and young adults: possible modulation by testosterone in menBritish Journal of Clinical Pharmacology, 2003